Clinical trials recruiting for Breast Atypical Hyperplasia
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
US states with sites
1
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Tamoxifen | 2 |
| Acolbifene Hydrochloride | 1 |
| Omega-3-Acid Ethyl Esters | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Kansas | 2 |
| Ohio | 2 |
| California | 1 |
| Illinois | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Related conditions
Trials recruiting for Breast Atypical Hyperplasia often also study these conditions. Each links to its own recruiting-trial list.
Breast Lobular Carcinoma In Situ 4Breast Ductal Carcinoma In Situ 8Breast Carcinoma 74Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Atypical Hyperplasia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.